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Abstract
Background: More than half of the approximately 500,000 women diagnosed with cervical cancer
worldwide each year will die from this disease. Investigation of genes expressed in precancer
lesions compared to those expressed in normal cervical epithelium will yield insight into the early
stages of disease. As such, establishing a baseline from which to compare to, is critical in elucidating
the abnormal biology of disease. In this study we examine the normal cervical tissue transcriptome
and investigate the similarities and differences in relation to CIN III by Long-SAGE (L-SAGE).
Results: We have sequenced 691,390 tags from four L-SAGE libraries increasing the existing gene
expression data on cervical tissue by 20 fold. One-hundred and eighteen unique tags were highly
expressed in normal cervical tissue and 107 of them mapped to unique genes, most belong to the
ribosomal, calcium-binding and keratinizing gene families. We assessed these genes for aberrant
expression in CIN III and five genes showed altered expression. In addition, we have identified
twelve unique HPV 16 SAGE tags in the CIN III libraries absent in the normal libraries.
Conclusion:  Establishing a baseline of gene expression in n o r m a l  c e r v i c a l  t i s s u e  i s  k e y  f o r
identifying changes in cancer. We demonstrate the utility of this baseline data by identifying genes
with aberrant expression in CIN III when compared to normal tissue.
Background
Approximately 500,000 women are diagnosed with cervi-
cal cancer worldwide each year and more than half of
them will die from this disease [1]. The highest incidence
rates are observed in developing countries where it is the
second most prevalent cancer in women and remains a
leading cause of cancer related death [1]. Widely imple-
mented screening programs have been responsible for the
much lower incidence and mortality rates seen in the
developed world. Present day screening methods prima-
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rily identify precancer lesions termed cervical intraepithe-
lial neoplasia (CIN). CIN lesions are classified into three
subgroups, CIN I, CIN II and CIN III, corresponding to
mild, moderate and severe dysplasia/carcinoma in situ
(CIS), respectively. CIN III lesions have a high likelihood
of progression to invasive disease if left untreated [2].
Human Papillomavirus (HPV) has long been established
as a necessary but not sufficient cause for cervical carci-
noma development. HPV is detected in 99% of invasive
disease, 94% of CIN lesions and 46% of normal cervical
epithelium [2]. The high risk strains HPV 16 and HPV 18
are most prevalent in invasive disease.
A comprehensive characterization of gene expression of
the normal cervical tissue is critical to establish a baseline
for comparison against transcriptomes of precancer and
cancer. A recent report described the global expression of
genes in cervical epithelium using a serial analysis of gene
expression (SAGE) based method, enumerating 30,418
sequence tags generated from one normal uterine ectocer-
vical tissue [3]. Another study compared cDNA microar-
ray profiles of cervical tissue to exfoliated cervical cells
used in cytology-based cancer screening [4].
In this study, we increased the depth of our understanding
of the normal cervical transcriptome and identified gene
expression changes in CINIII. We achieved this (i) by
using an unbiased Long SAGE (L-SAGE) approach to
improve the accuracy of tag-to-gene mapping [5-7], and
(ii) by examining 691,390 L-SAGE tags thus increasing
publicly available cervical SAGE data by greater than 20
fold.
Results
In this study, we sequenced 691,390 SAGE tags from four
libraries. Cervical L-SAGE libraries N1, N2, C1, and C2
were sequenced to 165,624, 181,224, 173,534, and
171,008 tags, respectively. Duplicate ditags were elimi-
nated from analysis resulting in 136,276, 139,656,
154,828 and 136,386 useful tags respectively and a total
of 24, 058 unique tags (Figure 1A). 15,438 of the unique
tags mapped to annotated UniGene identifiers. The raw
data of the sequence tags have been made publicly availa-
ble (Gene Expression Omnibus, series accession number
GSE6252). We characterized the transcriptome of normal
cervical tissue and evaluated the highly expressed genes in
terms of tissue specificity, concordant expression among
the normal libraries and their altered expression in CIN III
lesions (Figure 1B).
Genes Highly Expressed in Normal Cervical Epithelium
118 unique tags were found to be highly expressed in the
normal cervical epithelium (at >500 tpm in both normal
libraries). 103 of these tags mapped to UniGene clusters
and represent 100 unique genes and hypothetical proteins
(Figure 1). Manual examination of tags not mapped by
SAGE Genie yielded three additional tags. This results in a
total of 107 unique tag-to-gene mappings and 103 unique
genes. The abundance of the 118 tags and the genes they
represent are summarized in Table 1.
To determine cervical tissue specific expression, we first
investigated the expression of the 107 genes using expres-
sion data available at the National Center for Biotechnol-
ogy Information (NCBI) Unigene database and the
National Cancer Institute (NCI) Cancer Genome Anat-
omy Project (CGAP) SAGE Anatomical Viewer. Based on
CGAP information, only four of the 107 genes were
unique to cervical tissue: carcinoembryonic antigen-related
cell adhesion molecule 7 (CEACAM7), keratin 6A (KRT6A),
small proline-rich protein 3 (SPRR3) and S100 calcium bind-
ing protein A7 (S100A7). These genes were further investi-
gated for expression by RT-PCR in 20 different tissue types
and three normal cervical specimens (Figure 2).
CEACAM7 was found to be expressed in colon, larynx,
pancreas and two of the three normal cervical specimens.
KRT6A  expression was detected in placenta, thymus,
tongue, prostate, larynx, colon, skin and in all three of the
normal cervical specimens. SPRR3  was found strongly
expressed in placenta, thymus, colon, tongue, larynx and
all three of the normal cervical cases. S100A7  showed
expression in placenta, thymus, and tongue and in all
three of the normal cervical specimens. All four genes
were prominently expressed in the cervical epithelium but
this combination of genes was not expressed in the tissues
examined (Figure 2).
Flow diagram of SAGE analysis and tag-to-gene mapping Figure 1
Flow diagram of SAGE analysis and tag-to-gene mapping. A. 
Sequence tags yielded from the four SAGE libraries were cat-
agorized. Useful tags indicate all sequenced tags less duplicate 
ditags. B. The abundance and classification of unique tags in 
the SAGE libraries of normal cervix tissue (N1, N2) are sum-
marized.
Tag Analysis Summary for Normal 
Cervical Libraries 
4 Cervical Tissue 
L-SAGE Libraries
691,390 tags  sequenced
24,058 unique tags
15,438 with 
UniGene 
identifiers
8,620 without 
UniGene 
identifiers
118 tags >500 tpm 
in N1 and N2
103 unique genes
431 tags with concordant 
expression in N1 and N2
351 unique genes
358 map to 
UniGene identifiers
107 map to 
UniGene identifiers
567,146 
useful tags  
124,244 
duplicate ditags 
Normal Cervical Tissue 
Derived Libraries (N1 and N2)
All Cervical Tissue Libraries 
4 genes offer
a gene signature
unique to normal 
cervical tissue
5 genes show
altered expression 
in C1 and C2
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Table 1: Tags expressed in normal cervical libraries at ≥500 tags per million.
Gene Symbol N1 tpm N2 tpm C1 tpm C2 tpm SAGE Tag
unknown 2510 3623 2655 873 TGATTTCACTTCCACTC
u n k n o w n 2 5 1 73 4 3 03 3 0 71 6 7 2 C T A A G A C T T C A C C A G T C
unknown 594 559 497 594 GTAGGGGTAAAAGGAGG
u n k n o w n 2 0 3 31 6 8 32 2 8 01 2 3 9 C A C C T A A T T G G A A G C G C
unknown 807 852 1298 0 CAAGCATCCCCGTTCCA
unknown 822 680 814 631 AGGTGGCAAGAAATGGG
u n k n o w n 3 7 5 72 7 1 44 1 3 42 7 5 7 A C T T T T T C A A A A A A A A A
unknown 616 687 782 374 ACTAACACCCTTAATTC
unknown 1519 1525 2222 2126 AAAAAAAAAAAAAAAAA
unknown 565 780 588 308 TTTAACGGCCGCGGTAC
unknown 6289 6602 6510 4326 TTCATACACCTATCCCC
ACTB 2099 1031 1292 1459 GCTTTATTTGTTTTTTT
ACTG1 1424 1955 1195 1598 CTAGCCTCACGAAACTG
ANXA1 3713 6480 3701 10162 AGAAAGATGTCTATGTA
ANXA2 1644 1754 1298 887 CTTCCAGCTAACAGGTC
AQP3 609 573 930 1136 TTTGCTTTTGTTTTGTT
ATP5G3 543 773 743 851 GGAATGTACGTTATTTC
B2M 8718 2821 9443 5712 GTTGTGGTTAATCTGGT
BZRP 550 960 794 675 GAATTTTATAAGCTGAA
CCNB1IP1 580 924 988 565 CCACTGCACTCCAGCCT
CD24 851 559 775 697 GGAACAAACAGATCGAA
CD74 2348 573 1789 1444 GTTCACATTAGAATAAA
CEACAM7 793 866 891 594 AATCACAAATAAAAGCC
CFL1 1937 1031 1744 1679 GAAGCAGGACCAGTAAG
COX4I1 646 523 969 616 CCTATTTACTGGAAACC
CSTB 712 3881 1227 2676 ATGAGCTGACCTATTTC
CTSD 2502 931 2894 1987 GAAATACAGTTGTTGGC
EEF1A1 2245 1353 1737 1496 TGTGTTGAGAGCTTCTC
EEF1B2 961 1210 1072 1298 GCATTTAAATAAAAGAT
EEF1G 726 501 807 418 TGGGCAAAGCCTTCAAT
FLJ20701 550 501 685 264 ATTTGAGAAGCCTTCGC
FTH1 2311 1275 2325 5176 TTGGGGTTTCCTTTACC
GAPD 1666 2363 2312 2816 TACCATCAATAAAGTAC
GJA1 741 1310 504 513 TGTTCTGGAGAGTGTTC
GLUL 1658 1275 1905 2845 TACAGTATGTTCAAAGT
IGHG1 14118 788 349 4715 GAAATAAAGCACCCACC
IGHG1 18286 773 601 6548 GAAATAAAGCACCCAGC
ITM2B 1203 1031 1369 865 TAAGTAGCAAACAGGGC
K-ALPHA-1 1181 795 1783 1239 TGTACCTGTAATATTTT
KRT13 1380 8206 1815 2046 AAAGCGGGGCTGGAGAA
KRT15 1152 3494 2713 2427 TAATAAAGAATTACTTT
KRT5 2216 1539 1892 1371 GCCCCTGCTGACACGAG
KRT6A 1181 2657 975 1166 AAAGCACAAGTGACTAG
LAMR1 2987 2370 3268 2911 GAAAAATGGTTGATGGA
LGALS7 682 2220 446 425 TAAACCTGCTGTGCGGG
LOC44051 719 702 588 719 GGGTTGGCTTGAAACCA
LY6D 1424 2248 1796 3072 GAGATAAATGATTTAAA
MGC71999 998 1353 924 565 TCACAAGCAAATGTGTC
MYL6 1115 559 995 1063 GTGCTGAATGGCTGAGG
NET-5 1783 780 1298 997 CACAAACGGTAGTTTTG
PERP 1306 2828 1828 2236 CCACAGGAGAATTCGGG
PLCB4 866 752 1072 733 AAAACATTCTCCTCCGC
P P I A 1 5 0 41 6 9 71 9 5 11 4 5 2 C C T A G C T G G A T T G C A G A
PTMA 1049 1017 1518 697 TTCATTATAATCTCAAA
RPL10 2223 1797 1944 1283 AGGGCTTCCAATGTGCT
RPL10A 998 652 1414 821 GGCAAGCCCCAGCGCCT
RPL11 1130 773 1124 829 CGCTGGTTCCAGCAGAA
RPL12 932 580 865 726 ACATCATCGATGACATC
RPL13A 2818 1998 2855 2383 AGGCTACGGAAACAGGCBMC Genomics 2007, 8:142 http://www.biomedcentral.com/1471-2164/8/142
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RPL13A 1490 716 1434 1195 CTCCTCACCTGTATTTT
RPL21 2091 1353 1899 1554 GCATAATAGGTGTTAAA
RPL23 1196 1031 1072 1114 ATTCTCCAGTATATTTG
RPL27A 1923 1310 1989 1899 GAGGGAGTTTCATTAAA
RPL28 1996 1504 1983 1833 GCAGCCATCCGCAGGGC
RPL29 1049 773 1104 814 GGGCTGGGGTCCTCCTG
RPL3 917 702 840 983 GGACCACTGAAGAAAGA
RPL30 1541 1017 1259 961 CCAGAACAGACTGGTGA
RPL31 609 573 568 491 AAGGAGATGGGAACTCC
RPL32 1512 1024 1550 1371 TGCACGTTTTCTGTTTA
RPL35 638 551 665 572 CGCCGCCGGCTCAACAA
RPL36 1570 1275 1628 1173 AGGAAAGCTGCTGCCAA
RPL37 5063 3272 6362 6064 CAATAAATGTTCTGGTT
RPL37A 1350 938 1259 953 AAGACAGTGGCTGGCGG
RPL4 521 537 465 359 CGCCGGAACACCATTCT
RPL41 2649 1812 2609 1906 TTGGTCCTCTGCCCTGG
RPL7 1702 1160 1427 1180 ATTATTTTTCTAAGCTG
RPLP0 815 1239 846 601 CTCAACATCTCCCCCTT
RPLP1 3574 2735 3507 2398 TTCAATAAAAAGCTGAA
RPLP2 2422 1461 2196 2376 GGATTTGGCCTTTTTGA
RPS11 1365 802 917 770 TCTGTACACCTGTCCCC
RPS12 690 695 601 396 GCCGAGGAAGGCATTGC
RPS14 1159 859 1240 843 TAAAAAAAAAAAAAAAA
RPS18 1071 1053 1085 858 TGGTGTTGAGGAAAGCA
RPS19 2598 1604 2357 2618 CTGGGTTAATAAATTGC
RPS20 903 695 1020 667 GCTTTTAAGGATACCGG
RPS23 961 637 833 704 CTGTTGGTGATATTCCT
RPS25 1042 988 924 660 AATAGGTCCAACCAGCT
RPS26 2576 1002 1938 873 TAAGGAGCTGAGTTCTT
RPS27A 815 623 988 887 AACTAAAAAAAAAAAAA
RPS28 998 902 1053 1034 GACGACACGAGCCGATC
RPS29 2245 1940 2325 2317 ATAATTCTTTGTATATA
RPS3A 1218 823 1427 1232 GTGAAGGCAGTAGTTCT
RPS4X 1541 952 1615 924 TCAGATCTTTGTACGTA
RPS8 4021 3587 4282 3996 TAATAAAGGTGTTTATT
RPS9 587 530 407 521 CCAGTGGCCCGGAGCTG
S100A10 514 501 543 506 AGCAGATCAGGACACTT
S100A2 2950 723 2235 3505 GATCTCTTGGGCCCAGG
S100A7 2899 752 388 5990 GAGCAGCGCCCTGTTCC
S100A8 690 1031 827 1466 GCTTTTTTTGTGGGCTG
S100A8 11880 25205 8855 24629 TACCTGCAGAATAATAA
S100A9 13561 17078 10089 18660 GTGGCCACGGCCACAGC
SERPINB3 1137 1454 704 917 CCTTTCTCTCTTTCTCT
SFN 1255 1976 1505 1569 TTTCCTCTCAATAAAGT
SMAD2 2935 2341 3378 1987 CCCATCGTCCTAGAATT
SPINK5 712 4189 0 1305 TCCACCAAGTCTGAGCC
SPRR3 1600 11757 3888 5968 TTTCCTGCTCTGCCCTC
SPRR3 1636 13068 4121 8329 TTTCCTGCTCTTCCCTC
STX3A 646 1905 1318 1312 TAAAATGTTTATGATAA
SUI1 1446 1239 1259 2009 CAATAAACTGAAAAGAG
TAGLN2 660 616 769 543 GTCTGGGGCTTGAGGAA
TMSB4X 2245 616 1175 917 TTGGTGAAGGAAGAAGT
TPI1 947 1382 1589 1584 TGAGGGAATAAACCTGG
TPT1 4726 3659 4915 4568 TAGGTTGTCTAAAAATA
TXNL5 660 838 258 924 TTAGCAATAAATGATGT
UQCRH 646 508 930 726 GGTTTGGCTTAGGCTGG
VAMP8 521 795 459 491 TGGCTGGGAAACTGTTG
VPS13B 763 594 911 0 CACTACTCACCAGACGC
YWHAZ 587 702 517 814 TAAGTGGAATAAAAGTT
Table 1: Tags expressed in normal cervical libraries at ≥500 tags per million. (Continued)BMC Genomics 2007, 8:142 http://www.biomedcentral.com/1471-2164/8/142
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Disrupted Gene Expression in CIN III
All tags were assessed for altered expression in CIN III.
Four hundred and seventy-six tag show greater than two
fold increase in CIN III and are expressed at greater than
15 tpm (see Additional file 1) while 315 tags were
decreased in CIN III (see Additional file 2).
We determined if the expression of the 107 unique tags,
that were highly expressed in normal cervical libraries (>
500 TPM), were disrupted in CIN III. Comparison of
expression levels in N1, N2 to the CIN III libraries using
the Z-test revealed five differentially expressed genes
(Table 2). Annexin 2 (ANXA2), galectin 7 (LGALS7) and
connexin 43 (GJA1) exhibited decreased expression in CIN
III (Z < -1.96) while aquaporin 3 (AQP3) and ribosomal-like
protein 37 (RPL37) increased in expression (Z > 1.96).
Real-time PCR was performed on a panel of 6 new cervical
specimens, three each of normal and CIN III for all five of
these genes (Figure 3). Expression results were normalized
to housekeeping gene ACTB and 18S (Figure 3A and 3B,
respectively). Decrease in expression of ANXA2, LGALS7
and  GJA1  in CIN III was confirmed while increase in
expression of AQP3 and RPL37 were not.
Viral (HPV 16) tags in L-SAGE libraries
HPV transcripts were also detected by L-SAGE. Tags from
all four libraries were mapped against the genomes of
HPV 16 and HPV 18. While no tags mapped to HPV 18,
twelve tags from the CIN III libraries mapped to the more
prevalent HPV 16 genome (Table 3). The highest tran-
script counts of known genes belonged to E5 at 1,180 and
290 tpm and E2 at 240 and 20 tpm, in libraries C2 and
C1, respectively. Compared by BLAST [8] against the Ref-
Seq Genome collection, none of the twelve tags matched
100% to the human genome. All twelve tags were also
mapped against human transcript sets (mitochondrial
genome, RefSeq, UCSC gene set, Unigene, Ensembl,
UCSC mRNA, UCSC EST, SAGEmap and SAGEgenie
SAGE tag sets). No tags matched to any of the described
transcript sets with the exception of CATGCACGCTTTT-
TAATTACA and CATGTGTATGTATTAAAAATA which
mapped to human EST BF909200. The full length EST
sequence is 97% identical with the HPV 16 E5 gene and
was likely amplified from HPV sequences in the originat-
ing uterine tumour lesion.
Discussion
This study represents the most comprehensive gene
expression analysis of cervical tissue reported to date. In
total, 691,390 L-SAGE tags were sequenced (Figure 1A).
The length of the L-SAGE tags (21 bp as compared to 14
bp in conventional SAGE) greatly reduces tag-to-gene
mapping ambiguity [6]. 107 of the 118 (88%) highly
expressed tags (i.e. >500 tpm) were mapped to known
genes or hypothetical proteins encompassing 103 unique
genes (Figure 1B).
Assessing Highly Expressed Tags by Functional Group
Of the 107 highly expressed tags (>500 tpm), 47 were
expressed at extremely high levels (>103 tpm) including
genes frequently used as controls in expression analysis,
GAPDH and ACTB. High expression of 20 genes in normal
Validation of tissue specificity of gene expression Figure 2
Validation of tissue specificity of gene expression. Reverse 
transcriptase PCR of four genes in 20 tissue types and three 
normal cervical specimens. Heart (Ht), breast (Br), placenta 
(Pl), lung (Lg), liver (Lv), skeletal muscle (Sk), kidney (Kd), 
pancreas (Pn), spleen (Sp), thymus (Ty), prostate (Pr), testis 
(Ts), ovary (Ov), small intestine (Sm), colon (Co), peripheral 
leukocytes (Lk), tongue (Tg) larynx (Lx), stomach (St), skin 
(Sn). Ca, Cb and Cc are three individual normal cervical tis-
sue specimens.
Ht      Br      Pl      Lg     Lv        Sk    Kd    Pn     Sp      Ty
Pr     Ts     Ov     Sm     Co       Lk    Tg     Lx     St      Sk       Ca      Cb     Cc
KRT6A
CEACAM7
S100A7
SPRR3
KRT6A
CEACAM7
S100A7
SPRR3
Table 2: Highly expressed genes with altered expression in CIN III.
Z_Score a
Tag N1 tpm N2 tpm C1 tpm C2 tpm N1 vs C2 N1 vs C1 N2 vs C2 N2 vs C1 Gene Symbol
TTTGCTTTTGTTTTGTT -4.7 -3.1 -5.1 -3.5 AQP3
CAATAAATGTTCTGGTT 5063 3272 6362 6064 -3.5 -4.6 -10.8 -12 RPL37
TGTTCTGGAGAGTGTTC 741 1310 504 513 2.4 2.6 6.9 7.3 GJA1
TAAACCTGCTGTGCGGG 682 2220 446 425 2.9 2.7 12.9 13.4 LGALS7
CTTCCAGCTAACAGGTC 1644 1754 1298 887 5.6 2.4 6.3 3.2 ANXA2
a Z > 1.96; reduced expression in CIN III, Z < -1.96; increased expression in CIN III.BMC Genomics 2007, 8:142 http://www.biomedcentral.com/1471-2164/8/142
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cervical tissue was reported in a previous study [3]. Fifteen
of these genes are encompassed by our list of 107 high
expressers. The most highly expressed tags expressed at
>104 tpm (GTGGCCACGGCCACAGC and TACCTGCA-
GAATAATAA) mapped to the genes S100A9 and S100A8,
respectively. Both genes belong to the calcium binding
protein family. These findings are in agreement with a pre-
vious report of high S100A8 and S100A9 levels in cervical
tissue [3]. Although the function of these genes is not well
understood, genes within this family have been proposed
to participate in a variety of cellular process including cell
cycle, wound healing and cell differentiation [9].
Assigning the 103 highly expressed genes to one of eleven
broad functional groups allowed for an assessment of
those cellular processes represented by the most abundant
transcripts. These cellular processes include calcium bind-
ing proteins, cell cycle or cell death, cytoskeleton,
immune functioning, keratinization, membrane proteins,
mitochondrial, protein processing, translation (ribos-
omal proteins), translation (non ribosomal proteins)
with a small fraction of tags mapping to other functional
groups or to genes with no known function (Figure 4A).
The 41 ribosomal genes account for the greatest propor-
tion of highly expressed genes at 28% and 31% (normal
and CIN III, respectively). In contrast, only five calcium
binding genes account for the second largest functional
subgroup of highly expressed tags, 18% and 19% (normal
and CIN III, respectively).
The relative expression levels of the functional groups do
not change greatly between the normal and CIN III librar-
ies however the keratin and immune related functional
groups show slight decrease from 12% and 17% in CIN III
to 9% and 14% in normal tissue (keratin and immune
groups, respectively).
All tags expressed at or greater than 15 tpm in Normal and
CIN III libraries (2,814 and 3,279 respectively) were also
Table 3: Tags mapping to HPV16 genome.
Tag Strand Gene N1 tpm N2 tpm C1 tpm C2 tpm
CATGCACGCTTTTTAATTACA + E5 0 0 290 1,180
CATGCAACATAAATAAACTTA + - 0 0 6 770
CATGGCATTGGACAGGACATA + E2 0 0 6 240
CATGTGTATGTATTAAAAATA - E5 0 0 6 155
CATGACACAATAGTTACACAA + - 0 0 6 125
CATGGGGAGGAATATGATTTA + L1/L2 0 0 0 30
CATGTAGACGACACTGCAGTA - E2 0 0 0 20
CATGGTAGATTATGGTTTCTG - E7 0 0 6 7
CATGTCGTAGGTACTCCTTAA - L1/L2 0 0 0 7
CATGGGGATCCTTTGCCCCAG - L1/L2 0 0 0 7
CATGATAATATATGTTTGTGC - L1/L2 0 0 0 7
CATGCGCCTAGAATGTGCTAT + E2 0 0 0 0
Summary of test panel quantitative PCR results of genes with  altered expression in CIN III L-SAGE libraries Figure 3
Summary of test panel quantitative PCR results of genes with 
altered expression in CIN III L-SAGE libraries. A panel of 
three new CIN III cases (CIN III A, CIN III B, CIN III C) were 
investigated for expression and compared to three new nor-
mal specimens. Gene expression was normalized to ACTB 
and 18S (Figure 3A and 3B, respectively). Zero on the Y-axis 
denotes mean expression levels of the respective genes in 
normal cervical tissue. All five genes investigated showed 
decreased expression.
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evaluated according functional group using Onto-Express
(see Additional File 3) [10]. The most represented groups
included DNA dependent transcription regulators and
transcription in both the Normal and CIN III libraries.
Cervical Tissue Gene Signature
Four of the 103 unique genes we found to be abundantly
expressed in normal cervical tissue were documented to
have limited or no expression in other tissues according to
the web resources NCBI UniGene [11] and NCI CGAP
SAGE Anatomical Viewer [12,13] (Figure 1B). These genes
(CEACAM7, SPRR3, S100A7 and KRT6A) are our candi-
dates for an expression signature unique to normal cervi-
cal tissue and were further investigated in a panel of 20
different tissue types and three new normal cervical spec-
imens. We found that all four of these genes were not
abundantly expressed simultaneously in any of the 20 tis-
sues examined (Figure 2). Placenta, thymus and tongue
were found to express a combination of three genes
(S100A7,  SPRR3  and  KRT6A), while colon expressed
another combination (CEACAM7,  SPRR3  and  KRT6A).
KRT6A and SPRR3 expression was observed in larynx tis-
sue with only minimal expression detected for S100A7
and  CEACAM7. In contrast, two of the cervical cases
strongly expressed all four genes investigated while only
the third showed very low CEACAM7 expression. Signifi-
cantly, our study is the first to document CEACAM7
expression in cervix. The data suggest that abundant
expression of CEACAM7 and S100A7 collectively, are
unique to cervical tissue and have the potential to serve as
useful biomarkers in identifying origins of metastatic dis-
ease.
It is interesting to note that decreased expression of three
of the genes is linked to abnormal growth and organiza-
tion of epithelium. For example, CEACAM7 is a member
of the carcinoembryonic antigen family of genes and
expression has been documented in highly differentiated
normal colon epithelium and the apical surface of normal
ductal pancreas epithelium, while loss of expression has
been reported in colon hyperplastic polyps [14]. Another
member of this gene family, CEACAM1, is shown to have
no or very low expression in cervical carcinoma [15].
Decreased expression of KRT6A and S100A7 have been
associated with breast, lung and ovarian cancer [16-20].
SPRR3 belongs to the class of small proline rich genes
which are expressed in differentiated keratinocytes and
has previously been shown to be highly expressed in nor-
mal cervical tissue [21].
Genes Altered in Expression in CIN III
The 107 highly expressed unique tags in the normal librar-
ies were assessed for expression changes in CIN III. Two
genes showed increased expression (AQP3 and RPL37)
while three genes declined in transcript counts in the CIN
III libraries (ANXA2, GJA1  and LGALS7). All five were
evaluated by real-time PCR in a new cervical tissue panel.
Results for ANXA2, LGALS7 and GJA1 confirmed L-SAGE
findings.
Panel results for GJA1  are in agreement with those
reported by King et al. in that GJA1  expression was
detected in normal cervical epithelium while reduced
expression was observed in CIN III lesions investigated
[22]. It has been suggested that this pattern may be a con-
sequence of epithelial disorganization and not causative
in dysplasia development [23,24].
The high expression of LGALS7 in normal cervical epithe-
lium contrasted by the low expression seen in the CIN III
lesions in the tissue panel we report here is similar to
those expression patterns seen in studies of other normal
tissue types compared to their respective carcinomas
including cornea and larynx [25]. LGALS7 expression has
been hypothesized in all stratified epithelium tissue types
Functional groupings of tags highly expressed (>500 tpm) in  normal libraries Figure 4
Functional groupings of tags highly expressed (>500 tpm) in 
normal libraries. Categories are as described. The Other 
group consists of tags which map to known genes but are not 
encompassed by any of the ten categories. The Unknown 
function group consists of tags mapping to no known genes. 
A) Tag counts in the normal libraries are categorized by 
functional group. B) Tags found in A were quantified in both 
CIN III libraries and categorized according to the same func-
tional grouping scheme. In both groups Ribosomal genes 
accounted for the greatest number of tags while only the 
keratins changed in expression or were decreased in the 
CIN III libraries.
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and has been experimentally detected in human cornea,
heart, larynx, tongue, skin, thymus and thyroid [26-28].
Though, LGALS7 has been investigated in the context of
cell line models, it is interesting to note that expression of
this gene in cervical epithelium has not been previously
reported [26-28]. LGALS7 is one of fifteen members of the
B-galactoside-binding lectin family, some of which have
been shown to influence cell growth, cell cycle, apoptosis
and cell migration via their predicted role in homeostasis,
however, the role of LGALS7 in cancer is unclear [27,29].
Support for the pro-apoptotic function of LGALS7 was
reported by Kuwabara et al. and Bernard et al. who identi-
fied cells more sensitive to apoptosis when LGALS7
expression was high in the epithelium derived cells
[28,30,31]. In contrast, Demers et al. showed an increase
in LGALS7 expression in lymphoma cells and suggested a
positive role in cell growth and dispersal through induced
matrix metalloproteinase 9 (MMP9) expression [32]. We
did not observe a statistically significant change in MMP9
in the four libraries investigated. This variance in expres-
sion suggests multiple roles for LGALS7 that may be tis-
sue-type dependent.
The third gene investigated, ANXA2, is known to be highly
expressed in epithelial cells and is localized to the plasma
membrane and endosome. It has been suggested to func-
tion in linking membrane to membrane and membrane
to cytoskeleton [33]. The decrease in expression we
observe suggests that the loss of ANXA2 may be a causa-
tive factor in disorganisation of the epithelial architecture,
which is characteristic of cervical neoplastic lesions.
ANXA2 is also known to bind with S100A10 and partici-
pates in transport channel function across the plasma
membrane [33]. Interestingly, the ANXA2 binding site on
S100A10 also binds NS3, a viral protein from the blue-
tongue virus, and therefore directly competes with
ANXA2. The S100A10 protein has also been shown
inhibit Hepatitis B virus polymerase (HBV pol) activity
[34]. It is plausible that a S100A10-ANXA2 complex may
have a role in HPV infection or viral lifecycle. S100A10
expression was high and consistent in Normal and CIN III
libraries whereas ANXA2 decreased in the CIN III libraries.
The above real-time PCR results were normalized to the
widely accepted housekeeping gene ACTB (Figure 3A). For
comparison we also normalized the genes to a second
housekeeping gene 18S (Figure 3B). Briefly, results for
GJA1 and LGALS7 were in agreement to those when nor-
malizing to ACTB, however ANXA2  was shown to be
increased in CIN III as expected by the SAGE data. but this
does not concur with the QPCR results when normalized
to ACTB. One possible explanation is that on average, the
ACTB cycle threshold was >1.3 Ct lower in the CIN III
cases indicating an increase in ACTB expression in CIN III
lesions. Any Ct decrease less than this in the genes inves-
tigated would appear as a decrease in gene expression in
CIN III when normalized to ACTB but and increase when
normalized to 18S.
The real-time PCR results for AQP3 and RPL37 did not
concur with L-SAGE data and may be due to interindivid-
ual differences rather than a representation of changes
present in CIN lesions or cancer. It is interesting to note
that RPL37 overexpression in prostate cancer, colon can-
cer cell lines and clinical specimens have been reported
[35,36]. Our L-SAGE results also suggest a similar pattern
in cervical neoplasia. Results for these genes when nor-
malized to 18S showed an increase in expression in only
CIN III A (see Additional file 3).
Wong et al investigated gene expression in invasive cervi-
cal carcinoma by DNA microarray [37]. We investigated
this publicly available data through NCBI GEO [38].
Briefly, in this data, GJA1 showed a small decrease in
expression in invasive disease while LGALS7 was detected
in only four of the 26 specimens, three of which were nor-
mal tissue. Moderate AQP3 expression was detected in the
majority of cases including the control group. Expression
of ANXA2 and RPL37 was not assessed in the microarray
study.
Human L-SAGE Tags Map to the HPV Genome
HPV is an established etiological factor in cervical cancer
[2]. There are over 100 known strains of HPV, however
HPV 16 and HPV 18 are considered to be the frequent
high risk types owing to higher rates of persistent infec-
tion, higher rates of progression to cervical neoplasia, and
shorter median progression times than other HPV strains
[2]. HPV 16 is the most common strain and can be
detected in approximately 60% of cervical cancers, while
HPV 18 infection occurs in approximately 10–20%.
Uncontrolled expression of E6 and E7 genes from strains
16 or 18 are considered to be essential for oncogenic
transformation and function through inhibition of host
cell tumour suppressors p53 and the retinoblastoma pro-
tein (Rb) [2].
This is the first study to mine human SAGE libraries for
viral transcripts. Overall, CIN III library C2 (2,548 tpm)
possessed a greater number of tag counts from the more
prevalent HPV 16 strain when compared to C1 (320 tpm)
(Table 3). HPV 18 tags were not found in any library and
no viral tags were detected in the normal libraries. With
the exception of two tags, the viral tags expressed in cervi-
cal SAGE did not map to known human genes or
expressed sequences. The exceptions, CATGCACGCTTTT-
TAATTACA and CATGTGTATGTATTAAAAATA, mapped
to a single human EST isolated from a uterine tumour
(EST BF909200). The full length EST sequence is 97%
identical with the HPV 16 genome, more specifically theBMC Genomics 2007, 8:142 http://www.biomedcentral.com/1471-2164/8/142
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E5 gene, and therefore was likely amplified from HPV
sequences in the original lesion.
Tags mapping to the E5 gene accounted for the greatest
proportion of HPV tags mapping to known transcripts in
both C1 and C2 (93% and 52%, respectively). E5 is con-
sidered to be one of three HPV 16 oncogenes (E5, E6 and
E7) and is highly expressed in basal cells of premalignant
cervical lesions [39]. This expression declines as cells dif-
ferentiate and move toward the apical face of the epithe-
lium whereas E6 and E7 expression increases [39]. E5 is
detected throughout all epithelium layers in high grade
lesions such as CIN III. In contrast, expression is restricted
to layers closest to the basal cells in low grade lesions,
implying that E5 expression may be limited to undifferen-
tiated basal cells [40,41]. The high expression of E5 we
observe in the CIN III libraries and the absence of HPV 16
genes in the normal libraries is in concordance with such
studies.
An increase in sample size and inclusion of mild and
moderate stages of cervical intraepithelial neoplasia will
aid in quantifying the relationship between viral gene
expression and disease. This will also assist in further elu-
cidating genes important in early lesion transcriptome
events. A comparison of such events with those seen in
later stages will help to identify genes important in the
molecular pathogenesis of the disease.
Conclusion
In this study we have described the transcriptome of nor-
mal cervical tissues and compared against that of CIN III
lesions. This was achieved by construction of four L-SAGE
libraries and sequencing to the depth of 172,848 tags per
library on average. We highlighted that the Long-SAGE
technique provides a comprehensive profile of the tran-
scriptome without focusing on only known genes. Potent
tumour suppressors (e.g. PTEN), cell cycle mediators (e.g.
CCND1), and cellular respiration genes (e.g. NDUFA1)
were found to be tightly regulated in the normal libraries.
An expression signature of four highly expressed genes
(KRT6A, CEACAM7, S100A7 and SPRR3) in normal cervi-
cal epithelium was identified and confirmed, and three
abundantly expressed genes (ANXA2, GJA1 and LGALS7)
were found to have altered expression in CIN III. Further-
more, this is the first study to have identified viral tags in
human SAGE libraries demonstrating the versatile nature
of SAGE data, which allows for mining and re-mining
according to newly posed questions. HPV 16 E5  tran-
scripts were found most highly expressed while few E7
and no E6 transcripts were enumerated.
The identification of expression changes associated with
stages of disease progression will help further our under-
standing of cervical cancer development and potentially
elucidate novel targets for diagnosis and treatment. Estab-
lishing a baseline from which to compare is essential to
the identification of such aberrations and the 20 fold
increase in cervical gene expression data presented here is
a significant contribution to this effort.
Methods
Sample selection
The specimens were collected immediately prior to the
LEEP (Loop electrosurgical excision procedure) cone
biopsy targeting a small portion of the affected epithe-
lium. These specimens were collected with patient con-
sent at the Vancouver General Hospital Women's Clinic at
Vancouver Hospital & Health Science Centre. Cases were
assessed by cervical cancer pathologists at Vancouver Hos-
pital and Health Science Centre and were selected without
prior knowledge of HPV status. Specimens N1 and N2 in
this study were observed to be normal squamous epithelia
whereas C1 and C2 were identified as high grade dysplasia
or CIN III. Detailed information on specimen pathology
based on the LEEP cone specimens can be found in Addi-
tional file 4. All samples were stored immediately in RNA
later and stored at -80°C. Three cases each of CIN III (CIN
III A, CIN III B and CIN III C) and normal cervical tissue
(NA, NB and NC) which were used for target validation
through real-time PCR were also collected, assessed and
stored in the same manner.
L-SAGE Library Construction and Sequence Tag Analysis
The biopsies were individually homogenised in Lysis
Binding buffer (100 mM Tris-HCl, pH7.5, 500 mM LiCl,
10 mM EDTA, pH 8.0, 1% LiDS, 5 mM dithiothreitol).
Long SAGE libraries were constructed according to the L-
SAGE kit manual (Invitrogen, Ontario, Canada). Sequenc-
ing was performed at the BC Cancer Agency Michael
Smith Genome Sciences Centre. L-SAGE employs 21 base-
pair sequence tags, reducing the ambiguity in tag-to-gene
mapping that is sometimes encountered in classic SAGE
libraries which use 14 basepair sequence tags.
Data Analysis
Tags were mapped using the February 12, 2006 version of
SAGE Genie [13], and raw tag counts excluding duplicate
ditags were normalized to tags per million (tpm). A Z-test
analysis, standard for SAGE data analysis, was performed
as previously established by Kal et al. for comparison of
one SAGE library to another using an established cut-off
of 1.96 on the absolute Z-score to determine statistically
significant differences in expression levels between nor-
mal and CIN III [42].
Reverse Transcriptase PCR
For validation of cervical tissue gene signature, human
Multiple Tissue cDNA Panel I and II (Clontech, Missis-
sauga, Ontario) and total RNA for human larynx, skin,BMC Genomics 2007, 8:142 http://www.biomedcentral.com/1471-2164/8/142
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stomach and tongue (Stratagene, Cedar Creek, Texas)
were used. Five-hundred nanograms from larynx, skin,
stomach and tongue was used to generate cDNA. Final
concentrations of PCR reagents for cervical tissue signa-
ture were 0.5 µM primer, 2 mM MgCl2, 0.2 mM dNTP, 1×
PCR buffer (Invitrogen), 0.5 U Taq polymerase and 1 µL
of cDNA (annealing temperatures: 55°C (ACTB,
CEACAM7), 60°C (KRT6A), 65°C (SPRR3 and S100A7).
Total RNA for the panel of six cervical specimens used for
validation of genes was isolated using Trizol (Invitrogen)
and cDNA was generated using the High Capacity Taq-
Man Reverse Transcription Reagents, according to the
manufacturer's instructions (Applied Biosystems, Foster
City, CA).
Expression of genes selected by data analysis were ana-
lyzed by real-time PCR using TaqMan® Gene Expression
Assays on the ABI 7500 Real-Time PCR System (Applied
Biosystems, Foster City, CA), according to manufacturer's
instructions. Samples were run in duplicate and normal-
ized against an beta-actin  (ACTB) endogenous control
(HuACTB, Applied Biosytems). Assay IDs include AQP3,
Hs00185020_m1;  GAL7, Hs00170104_m1; RPL37,
Hs02340038_g1; and GJA-1, Hs00748445_s1. The rela-
tive quantification of these target genes in CIN III (CIN III
A, CIN III B and CIN III C) samples compared to normal
tissue (NA, NB and NC) samples was performed using the
established 2-∆∆Ct method, (Applied Biosystems, Relative
Quantitation Of Gene Expression, ABI PRISM 7700 Sequence
Detection System: User Bulletin #2). The cycle threshold
(Ct) value of the target gene was normalized to ACTB by
subtracting the Ct value for ACTB from that of the target
gene (∆Ct gene = Ct gene - Ct ACTB). This number was
then averaged from the three normal cases (ave ∆Ct nor-
mal). The mean fold change of each gene between normal
and CIN III was calculated using the following equation:
2 -(∆Ct gene - ave ∆Ct normal). The relative quantification values
were then plotted, one indicating no change with respect
to normal cervical tissue.
HPV Tag-to-Gene Mapping
Viral genomic sequence files (viral1.genomic.fna and
HPV11.txt) were downloaded from public repositories
and processed into 21 bp SAGE tags at every Nla III site in
both orientations using custom Perl scripts [43,44].
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